{ "market" : {"NAME" : "U.S.", "ID" : "us_market", "TZ" : "ET", "TZOFFSET" : "-18000", "open" : "1259332214", "close" : "1259344814", "flags" : {}} , "STREAMER_SERVER" : "http://streamerapi.finance.yahoo.com","arrowAsChangeSign" : false,"throttleInterval": "1000"}
ap

Threshold Pharmaceuticals 3Q loss widens on costs

Threshold Pharmaceuticals' 3rd-quarter loss widens on boost in costs, expenses

  • On 10:43 am EST, Friday November 6, 2009

REDWOOD CITY, Calif. (AP) -- Threshold Pharmaceuticals Inc., a development-stage biotechnology company, said late Thursday its third-quarter loss widened on higher research, development, and interest expenses.

The company lost $6.2 million, or 40 cents per share, compared with a loss of $4.6 million, or 49 cents per share, during the year-ago period.

Threshold reported no revenue, compared with $362,000 a year prior.

Operating expenses rose 4 percent to $5.2 million as the company continued developing its potential cancer treatment TH-302. Meanwhile, interest expense surged to $957,000 from $13,000.

Related Headlines

Top Stories

Related Message Boards

Sponsored Links

Copyright © 2009 The Associated Press. All rights reserved. The information contained in the AP News report may not be published, broadcast, rewritten, or redistributed without the prior written authority of The Associated Press.